Regulation of host physiology and immunity by microbial indole-3-aldehyde

Area of Science:

• Microbiome-host metabolic interactions
• Gut microbiota and host physiology
• Metabolite signaling in mammals

Background:

• Mammalian hosts and gut microbes exhibit co-evolution, leading to interconnected metabolic pathways.
• Tryptophan derivatives, like indole-3-aldehyde (3-IAld), exemplify microbial-host metabolic interplay.
• 3-IAld was initially recognized for enhancing epithelial barrier function via Aryl hydrocarbon Receptor agonism.

Purpose of the Study:

• To review the diverse roles of indole-3-aldehyde (3-IAld) in host physiology.
• To explore the involvement of 3-IAld in various pathological conditions.
• To discuss the immunomodulatory functions of 3-IAld.
• To evaluate the therapeutic potential of 3-IAld clinical development.

Main Methods:

• Literature review synthesizing existing research on 3-IAld.
• Analysis of studies investigating 3-IAld's impact on host physiology and pathology.
• Examination of research on 3-IAld's role in immune responses.

Main Results:

• Indole-3-aldehyde (3-IAld) exhibits a wide range of activities beyond its initial description.
• 3-IAld influences multiple physiological processes and is implicated in various diseases.
• Evidence suggests 3-IAld plays a significant role in host immunity.

Conclusions:

• Indole-3-aldehyde (3-IAld) is a key microbial metabolite with multifaceted roles in host health and disease.
• Further clinical development of 3-IAld holds promise as a novel therapeutic strategy.
• Understanding 3-IAld's mechanisms can advance treatments for various conditions.